RESEARCH TRIANGLE PARK – Pfizer is investing $19 million to create a new gene therapy production facility in RTP and could add up to 120 scientists and staff to operate it.
Information provided by Pfizer on Thursday says the company will move operations from a related facility in Chapel Hill that it acquired as part of a deal to buy Bamboo Therapeutics in 2016.
The new location is near the intersection of I-40 and I-540 in RTP.
According to the drug giant, an existing building will be retrofitted to accommodate production. It will provide facilities for drug substances, and related products as well as testing labs.
The news follows the recent announcement that Pfizer would invest $500 million and add some 300 jobs related to gene therapy at its campus in Sanford.
Construction will begin in 2020 with completion expected in 2022.
